- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Forum Financial Management Boosts AbbVie Stake by 16.9%
Investment firm increases holdings in pharmaceutical giant AbbVie in Q4 2025
Apr. 19, 2026 at 11:26am
Got story updates? Submit your updates here. ›
The intricate machinery and industrial processes behind AbbVie's drug development and production highlight the company's technological capabilities and commitment to innovation.North Chicago TodayForum Financial Management LP increased its position in AbbVie Inc. (NYSE:ABBV) by 16.9% in the fourth quarter of 2025, according to a recent 13F filing with the Securities and Exchange Commission (SEC). The investment firm now owns 72,626 shares of the company's stock, worth approximately $16.6 million.
Why it matters
AbbVie is a major pharmaceutical company with a diverse product portfolio spanning immunology, oncology, neuroscience, and other therapeutic areas. Institutional investors closely monitor changes in ownership of large-cap healthcare stocks like AbbVie, as these shifts can signal broader market trends and investor sentiment.
The details
Forum Financial Management LP added 10,481 shares of AbbVie to its portfolio during the fourth quarter, bringing its total holdings to 72,626 shares. This represents a 16.9% increase in the firm's position. AbbVie's stock price has fluctuated in recent months, with the share price ranging from $168.54 to $244.81 over the past 52 weeks.
- Forum Financial Management LP filed its 13F report for the fourth quarter of 2025 on April 19, 2026.
- The firm increased its AbbVie holdings during the three-month period ending December 31, 2025.
The players
Forum Financial Management LP
An investment management firm that oversees over $16 billion in client assets.
AbbVie Inc.
A global biopharmaceutical company focused on developing and commercializing specialty medicines across multiple therapeutic areas.
What they’re saying
“AbbVie's diverse product portfolio and pipeline in areas like immunology and oncology continue to attract interest from institutional investors.”
— Analyst
The takeaway
The increase in Forum Financial Management's AbbVie holdings reflects ongoing investor confidence in the pharmaceutical company's long-term growth prospects, despite recent stock price volatility. AbbVie's diverse drug pipeline and market-leading products in key therapeutic areas make it an attractive investment for institutional investors focused on the healthcare sector.
